The phosphodiesterase 5 inhibitor, sildenafil, further augments the compensatory upregulation of NO-cGMP signalling in hypoxic pulmonary hypertension

Kirsch, Mark; Weissmann, Norbert; Kemp-Harper, Barbara; Grimminger, Friedrich; Schmidt, Harald HHW

doi:10.1186/1471-2210-5-S1-P26

BMC Pharmacology

Article metrics
Last updated: Tue, 16 Apr 2024 2:42:07 Z

The phosphodiesterase 5 inhibitor, sildenafil, further augments the compensatory upregulation of NO-cGMP signalling in hypoxic pulmonary hypertension

Access & Citations

1344

Article Accesses
0

Web of Science
0

CrossRef

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.